Bijan Esfandiari

Widow of Reed Smith Attorney Seeks Paxil Suicide Rehearing

Sept. 10, 2018 – CHICAGO, IL - - The Seventh Circuit Court of Appeals panel that overturned a $3 million verdict against GlaxoSmithKline (GSK) for failing to include a suicide warning on the company’s antidepressant, Paxil, committed a “grave error,” said plaintiff Wendy Dolin in a petition for rehearing. Dolin’s attorneys, R. Brent Wisner, Michael L. [...]

By |2019-04-17T14:41:58-07:00September 10th, 2018|Blog, Press Releases, Michael L. Baum, Bijan Esfandiari, R. Brent Wisner|

Alere INRatio Lawsuits Claim: Inaccuracies Increased Risk of Injury

We are no longer accepting new Alere cases. The law firm of Baum, Hedlund, Aristei & Goldman has filed claims on behalf of several people who allege Alere INRatio blood monitoring products were defective and produced erroneous results, which caused serious injury or death. In late December, Plaintiffs’ attorneys Bijan [...]

Study Data Does Not Support Conclusion that FDA Warnings May Have Led to More Suicides

In a highly publicized article published in the British Medical Journal (BMJ) on June 18, 2014, “Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study,” Dr. Lu and colleagues suggest the FDA’s warnings regarding an increased risk of suicidality in children and [...]

By |2016-10-17T11:45:06-07:00November 15th, 2015|Pharma News, Bijan Esfandiari|

Stryker Strikes Out in Louisiana Federal Court, as Judge Rules Patient’s Products Liability Claims are Valid

We are no longer accepting OP-1 Putty medical device cases. Stryker Biotech’s attempts to have an OP-1 Putty/Calstrux Medical Device case against it dismissed have failed in Louisiana. The Honorable Brian Jackson, Chief Judge of the Middle District of Louisiana, ruled on December 22, 2014 that Williams F. Boutte, Jr.’s [...]

By |2018-04-30T12:26:08-07:00December 22nd, 2014|Stryker News, Medical Device News, Bijan Esfandiari|

Los Angeles Superior Court Rejects Preemption Argument, Allows Medtronic and Stryker Injury Case to Move Forward

A Los Angeles Superior Court judge rejected attempts by Stryker and Medtronic to dismiss Plaintiff April C. Cabana's claims that the devices used during two back surgeries caused her to suffer permanent disabling injuries. Cabana alleges the devices used during her surgeries were fraudulently promoted by the medical device companies for [...]

By |2016-10-17T11:52:30-07:00October 25th, 2013|Medtronic News, Stryker News, Medical Device News, Bijan Esfandiari|

California Judge Clears the Way for Baum Hedlund’s Medtronic INFUSE Bone Graft Device Lawsuit

On Monday, August 20, 2012, a California state court judge ruled in favor of a California resident, represented by Baum, Hedlund, Aristei & Goldman, allowing her lawsuit against Medtronic Sofamor Danek USA, Inc. and Medtronic, Inc. (collectively "Medtronic") to move forward. (The Judge previously issued a tentative ruling on Friday, August [...]

Pomona Valley Hospital Accused of Performing Experimental Surgical Research on Patients without Their Consent

Los Angeles, California, July 24, 2012 - - The Los Angeles-based law firm, Baum, Hedlund, Aristei & Goldman recently obtained documents in a lawsuit (Superior Court case no. BC465313) against two medical device manufacturers and Pomona Valley Hospital Medical Center that suggest the hospital may have conducted a non-consensual, uncontrolled, experimental "research [...]

By |2018-07-03T13:41:52-07:00July 24th, 2012|Stryker News, Medical Device News, Bijan Esfandiari|

Paxil Maker Loses Bid for Immunity from Suicidal Behavior Lawsuits

Seventh Circuit Rejects Preemption in a Baum Hedlund Antidepressant (Paxil) Suicide Case Summary: Paxil’s manufacturer, GlaxoSmithKline (Glaxo) has lost its bid for immunity from suicidal behavior lawsuits. A Federal Court of Appeals in Chicago rejected Glaxo’s attempt to throw out a case arising from the suicide of a 23-year-old university [...]

By |2018-02-27T14:03:19-08:00February 23rd, 2010|Paxil News, Pharma News, Press Releases, Bijan Esfandiari|

Court Denies GlaxoSmithKline Preemption in Tragic Paxil Suicide Attempt Case

Milwaukee, Wisconsin, August 7, 2009 -- A Wisconsin federal judge has denied GlaxoSmithKline’s claim of immunity from liability for a Paxil-induced injury case, allowing the plaintiffs product liability case to move forward. On March 17, 2004 Gary Forst, then 60, attempted suicide after two weeks of taking Paxil by slashing [...]

By |2018-02-27T14:06:58-08:00August 7th, 2009|Paxil News, Pharma News, Press Releases, Bijan Esfandiari|

Supreme Court Rules in Favor of Consumer Safety in Wyeth v. Levine

On Tuesday, March 4, 2009, the US Supreme Court ruled 6 to 3 in favor of a woman injured by Wyeth’s anti-nausea drug, Phenergan, stating that the company is not immune from liability based on the federal preemption defense. Federal Preemption is a recently developed defense used by drug manufacturers [...]

By |2018-02-27T14:50:24-08:00March 5th, 2009|Paxil News, Pharma News, Press Releases, Bijan Esfandiari|